BCR-ABL-IN-7

Modify Date: 2024-04-05 18:38:22

BCR-ABL-IN-7 structure	Common Name	BCR-ABL-IN-7
	CAS Number	688050-42-2	Molecular Weight	385.41
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₉H₁₆FN₃O₃S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of BCR-ABL-IN-7

BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor. BCR-ABL-IN-7 effectively inhibits activities of WT and T315I mutant ABL kinases. BCR-ABL-IN-7 can be used for the research of chronic myeloid leukemia (CML) research[1].

Name	WAY-328158
Synonym	More Synonyms

Description	BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor. BCR-ABL-IN-7 effectively inhibits activities of WT and T315I mutant ABL kinases. BCR-ABL-IN-7 can be used for the research of chronic myeloid leukemia (CML) research[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Bcr-Abl
References	[1]. Cao R, et al. Discovery of 2-Acylaminothiophene-3-Carboxamides as Multitarget Inhibitors for BCR-ABL Kinase and Microtubules. J Chem Inf Model. 2015 Nov 23;55(11):2435-42.

Molecular Formula	C₁₉H₁₆FN₃O₃S
Molecular Weight	385.41

3-Isoxazolecarboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-5-(4-fluorophenyl)-

BCR-ABL-IN-7

Use of BCR-ABL-IN-7

Names

BCR-ABL-IN-7 Biological Activity

Chemical & Physical Properties

Synonyms